Weight loss drugs containing GLP-1 agonists have exploded in popularity in recent years, gaining the interest of consumers for usage far beyond the FDA-approved purpose to treat type 2 diabetes and obesity
Starting at the lower end of this range and gradually increasing allows you to assess tolerance and response
If you were to experience serious side effects fevers, rash, vomiting, hives, blistering, muscle pain, or signs of an allergic reaction it would be best to stop using the peptide and contact your doctor immediately
Diabetic Retinopathy: Evidence from eight outcomes assessing diabetic retinopathy risk yielded predominantly non-significant findings
Consumer demand for Wegovy and Ozempic (semaglutide, from Novo Nordisk) created an FDA-official shortage, which temporarily allowed prescribers to work with compounding pharmacies and build weight management programs into their practices at a lower cost to consumers
They may feel stronger later than expected